Thirty year trends in testicular cancer mortality in Europe: Gaps persist between the East and West

Acta Oncologica

Volumn 51, Issue 7, 2012, Pages 956-958

  Znaor, Ariana ^a,b   Bray, Freddie ^c  

^a CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BULGARIA; CANCER MORTALITY; CZECH REPUBLIC; EASTERN EUROPE; EPIDEMIOLOGICAL DATA; ESTIMATED ANNUAL PERCENT CHANGE; HEALTH CARE COST; HUMAN; HUNGARY; ICELAND; INCIDENCE; LETTER; LUXEMBOURG; PRIORITY JOURNAL; TESTIS CANCER; WESTERN EUROPE;

EUROPE; EUROPE, EASTERN; HUMANS; MALE; MORTALITY; TESTICULAR NEOPLASMS;

EID: 84866356338     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.681701     Document Type: Letter

References (17)

1. Kvammen Ø, Tretli S, Johannessen T, Klepp O, Grotmol T. Testicular cancer risk according to country of birth and county of diagnosis in Norway, 1958-2007. Acta Oncol 2012;51:177-84.
2. Dahl O, Brydøy M. Testicular germ cell tumours-still many challenges. Acta Oncol 2012;51:147-50.
3. Haugnes HS, Laurell A, Stierner U, Bremnes R, Dahl O, Cavallin-Stahl E, et al. High-dose chemotherapy with autologous stem cell support in patients with metastatic nonseminomatous testicular cancer-a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA). Acta Oncol 2012;51:168-76.
4. Skoogh J, Steineck G, Stierner U, Cavallin-Stahl E, Wilderäng U, Wallin A, et al. Testicular-cancer survivors experience compromised language following chemotherapy: Findings in a Swedish population-based study 3-26 years after treatment. Acta Oncol 2012; 51:185-97.
5. Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality. Int J Cancer 2006;118:3099-111.
6. Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E. Western and eastern European trends in testicular cancer mortality. Lancet 2001;357:1853-4. (Pubitemid 32539122)
7. Levi F, Lucchini F, Boyle P, Negri E, La Vecchia C. Testicular cancer mortality in Eastern Europe. Int J Cancer 2003;105:574. (Pubitemid 36578566)
8. Bossetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F. Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urology 2011;60:1-15.
9. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011;60:304-19.
10. Boyle P. Testicular cancer: The challenge for cancer control. Lancet Oncol 2004;5:56-61. (Pubitemid 38072561)
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. [cited 2011 Apr 20]. Available from: http://globocan.iarc.fr.
12. WHO Databank. Geneva, Switzerland: WHO; 2012. [cited 2011 Mar 25]. Available from: http://www.who.int/whosis/mort/download/en/index.html.
13. Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: An overview. Eur J Cancer 2010;46:3040-52.
14. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, et al. Recent cancer survival in Europe: A 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784-96. (Pubitemid 47321601)
15. Bray F, Klint Å, Gislum M, Hakulinen T, Engholm G, Tryggvadótir L, et al. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol 2010;49: 644-54.
16. Aareleid T, Gondos A, Brenner H, Pokker H, Leppik K, Mägi M. Testicular cancer survival in Estonia: Improving but still relatively low. Acta Oncol 2011;50:99-105.
17. Gondos A, Bray F, Hakulinen T, Brenner H, EUNICE Survival Working Group. Trends in cancer survival in 11 European populations from 1990 to 2009: A model-based analysis. Ann Oncol 2009;20:564-73.